VALPIN 50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Valpin 50, and when can generic versions of Valpin 50 launch?
Valpin 50 is a drug marketed by Endo Pharms and is included in one NDA.
The generic ingredient in VALPIN 50 is anisotropine methylbromide. There is one drug master file entry for this compound. Additional details are available on the anisotropine methylbromide profile page.
Summary for VALPIN 50
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 596 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VALPIN 50 at DailyMed |
US Patents and Regulatory Information for VALPIN 50
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms | VALPIN 50 | anisotropine methylbromide | TABLET;ORAL | 013428-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |